Patent · US Active

Drug delivery device with end of dose feedback

US9962494B2 · kind B2 · utility

2Cited by

22References

14Claims

0Family size

Assignee

Sanofi-Aventis Deutschland GMBH · DE

Inventors

Stefan Blancke · Frankfurt am Main, DE
Axel Teucher · Frankfurt am Main, DE
Michael Jugl · Frankfurt am Main, DE
Christiane Schneider · Frankfurt am Main, DE

Key dates

Filing date	Nov 17, 2014
Grant date	May 8, 2018
Priority date	—
Expiry date	Jul 31, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M2205/582
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

A method and an assembly for providing a drug delivery device is presented. The assembly includes a housing and an end of dose feedback connection provides the user with an audible and/or tactile signal to indicate that the drug delivery is completed. A first section of the end of dose feedback connection is located on a distal portion of an inner sleeve and a second section of the end of dose feedback connection is located on the mid-body.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.